![]() | Up a level |
2023
Abboud, Tammam ORCID: 0000-0003-4379-6961, Melich, Patrick, Scheithauer, Simone, Rohde, Veit and Schatlo, Bawarjan
ORCID: 0000-0002-9221-0843
(2023).
Complications, Length of Hospital Stay, and Cost of Care after Surgery for Pyogenic Spondylodiscitis.
J. Neurol. Surg. Part A, 84 (1).
S. 52 - 58.
NEW YORK:
THIEME MEDICAL PUBL INC.
ISSN 2193-6323
2020
Bettag, Christoph, Abboud, Tammam, von der Brelie, Christian, Melich, Patrick, Rohde, Veit and Schatlo, Bawarjan (2020). Do we underdiagnose osteoporosis in patients with pyogenic spondylodiscitis? Neurosurg. Focus, 49 (2). ROLLING MEADOWS: AMER ASSOC NEUROLOGICAL SURGEONS. ISSN 1092-0684
2019
Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Weller, Johannes
ORCID: 0000-0001-5818-5392, Mack, Frederic, Tzaridis, Theophilos
ORCID: 0000-0001-9651-1144, Baehr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich
(2019).
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J. Neuro-Oncol., 144 (3).
S. 501 - 510.
NEW YORK:
SPRINGER.
ISSN 1573-7373
2018
Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Hau, Peter
ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Baehr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich and Glas, Martin
(2018).
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
J. Cancer Res. Clin. Oncol., 144 (8).
S. 1581 - 1590.
NEW YORK:
SPRINGER.
ISSN 1432-1335
2016
Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter
ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Haenel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Ruediger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tuettenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin
(2016).
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
J. Clin. Oncol., 34 (14).
S. 1611 - 1623.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
2014
Herrlinger, Ulrich, Schaefer, Nildas, Steinbach, Joachim Peter, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Braun, Christian, Kohnen, Ralf, Leutgeb, Barbara, Belka, Claus, Urbach, Horst, Stummer, Walter and Gies, Martin (2014). Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755